Innovative Asset Advisors Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$897K Buy
748
+195
+35% +$199K 0.39% 55
2026
Q1
$509K Buy
+553
New +$561K 0.29% 66

Other funds holding LLY

Innovative Asset Advisors Group's LLY Position: Q2 2026 in Review

Innovative Asset Advisors Group increased its Eli Lilly (LLY) stake by 35% in Q2 2026, buying an estimated $199K and bringing the position to 748 shares worth $897K. The position accounts for 0.39% of the portfolio, ranked #55.

Innovative Asset Advisors Group first reported a position in LLY in Q1 2026 and has held it in 2 quarters since. 4,431 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Innovative Asset Advisors Group held 748 shares of Eli Lilly worth $897K as of Q2 2026.
  • Innovative Asset Advisors Group bought 195 Eli Lilly shares in Q2 2026, an estimated $199K.
  • Eli Lilly made up 0.39% of Innovative Asset Advisors Group's portfolio in Q2 2026, its #55 holding.
  • Innovative Asset Advisors Group first reported a position in Eli Lilly in Q1 2026 and has held it in 2 quarters since.
  • 4,431 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Innovative Asset Advisors Group's 13F filing for Q2 2026, filed 5 Aug 2026.